Hela-GFP stable cells Puromycin
Order now: dominika@ksiazkiwnauce.pl
Hela-rtTA (GFP-Puro) stable cells |
|||
SC038-GP | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Puromycin fusion dual marker |
|||
Hela-RFP stable cells |
|||
SC031-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: RFP expression stable cell line in Hela cells with Puromycin marker. |
|||
GFP Expressing Human Glioblastoma Cells |
|||
TR01-GFP | Neuromics | 500,000 Cells | 1624.8 EUR |
Luciferase-2A-GFP, Hela stable cells (Blasticidin) |
|||
SC032-GB | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
Luciferase-2A-GFP, Hela stable cells (Neomycin) |
|||
SC032-GN | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
Hela-TetR (Puro) stable cells |
|||
SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
luciferase (firefly), HEK293 stable cells (GFP-Puromycin) |
|||
SC002-GP | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Luciferase (firefry) stable cell line with GFP-Puromycin dual marker. |
|||
GFP Expressing Human Gastric Carcinoma N87 Cells |
|||
TR02-GFP | Neuromics | 500,000 Cells | 1624.8 EUR |
GFP Expressing Human Renal Adenocarcinoma Cells (ACHN) |
|||
TR04-GFP | Neuromics | 500,000 Cells | 1624.8 EUR |
Luciferase (firefly), Hela stable cells (Blasticidin) |
|||
SC032-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Luciferase (firefry) expression stable cell line in Hela cells with Blasticidin marker. |
|||
Hela-rtTA (RFP-Bsd) stable cells |
|||
SC038-RB | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with RFP-Blasticidin fusion dual marker |
|||
GFP Expressing Human Prostate Carcinoma Cells (DU 145) |
|||
TR03-GFP | Neuromics | 500,000 Cells | 1624.8 EUR |
CRE stable cells with GFP-Puromycin dual marker |
|||
SC004-GP | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: CRE recombinase stable cell line with puromycin resistance and GFP fluorescent marker. |
|||
luciferase (firefly), HEK293 stable cells (Puromycin) |
|||
SC002-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
Description: Luciferase (firefry) stable cell line with Puromycin marker. |
|||
HEK293T / Luciferse stable cells (RFP-Puromycin) |
|||
SC002T-RP | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: HEK293T / Luciferase (firefry) expression cell line with RFP-Puromycin dual marker. |
|||
CRE stable cells with Puromycin marker |
|||
SC004-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
Description: CRE recombinase stable cell line with Puromycin resistance |
|||
luciferase (Renilla), HEK293 stable cells (Puromycin) |
|||
SC020-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1191.6 EUR |
Description: Luciferase (Renilla) stable cell line with Puromycin marker. |
|||
Luciferase-2A-RFP, Hela stable cells (Blasticidin) |
|||
SC032-RB | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
Luciferase-2A-RFP, Hela stable cells (Neomycin) |
|||
SC032-RN | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
luciferase (firefly), HEK293 stable cells (RFP-Puromycin) |
|||
SC002-RP | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Luciferase (firefry) stable cell line with RFP-Puromycin dual marker. |
|||
luciferase (Renilla), HEK293 stable cells (RFP-Puromycin) |
|||
SC020-RP | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Luciferase (Renilla) stable cell line with RFP-Puromycin dual marker. |
|||
MEF Feeder Cells (Puromycin-resistant) |
|||
CBA-312 | Cell Biolabs | 1 vial | 553.2 EUR |
Description: MEF Feeder Cells are mouse embryonic fibroblasts that allow stem cell culture without LIF. Cells must be mitotically inactivated prior to addition of stem cells. Puromycin resistant. |
|||
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
NHELA-100 | Alpha Diagnostics | 100 ug | 196.8 EUR |
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
NHELA-50 | Alpha Diagnostics | 50 ug | 153.6 EUR |
CRE stable cells with RFP-Puromycin dual marker |
|||
SC004-RP | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: CRE recombinase stable cell line with puromycin resistance and RFP fluorescent marker. |
|||
Inducible GFP Hela stable cell line |
|||
SC036 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: InducibleGFP expression stable cell line in Hela cells, with Neomycin and puromycin resitance |
|||
HeLa/GFP Cell Line |
|||
AKR-213 | Cell Biolabs | 1 vial | 686.4 EUR |
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
MCF7 / GFP (Puromycin) Stable Cell Line |
|||
SC050-G | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: GFP expression stable cell line in MCF7 cells with Puromycin resistance |
|||
Enhanced GFP Lentivirus (Puromycin) |
|||
78639-P | BPS Bioscience | 500 µl x 2 | 835 EUR |
Description: Enhanced green fluorescent protein (eGFP) is a modified (F64L and S65T mutations) version of the native GFP protein isolated from jellyfish (Aequorea victoria), with increased fluorescence and more efficient folding. The Enhanced GFP Lentivirus are replication-incompetent, HIV based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express eGFP under a CMV promoter. eGFP expression and transduction efficiency can easily be verified and optimized via fluorescence microscopy or flow cytometry. eGFP has an excitation wavelength of 488 nm, an emission wavelength of 509 nm, and extinction coefficient of 55,000 M-1cm-1. |
|||
SH-SY5Y / GFP (Puromycin) stable cell line |
|||
SC042 | GenTarget | 2 x 106 cell/ml x 1ml | 1017.6 EUR |
Description: GFP expression stable cell line in SH-SY5Y cells with Puromycin resistance |
|||
Puromycin |
|||
P097-100MG | TOKU-E | 100 mg | 452.4 EUR |
Puromycin |
|||
P097-25MG | TOKU-E | 25 mg | 154.8 EUR |
HEK293-GFP stable cells |
|||
SC001 | Cusabio | 2 x 106 cell/ml x 1ml | 669.6 EUR |
Description: GFP expression stable cell line in HEK293 cells with Blasticidin resistance |
|||
A549 / Luciferase-2A-GFP (Puromycin) stable cell line |
|||
SC043-LG | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
Description: Luciferase (firefry) and GFP co-expression stable cell line in A549 human cancer cell line with Puromycin marker. |
|||
ZR-75-1 / GFP (Puromycin) Stable Cell Line |
|||
SC051-G | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: GFP expression stable cell line in ZR-75-1 cells with Puromycin resistance |
|||
GFP-LacZ & RFP stable cells |
|||
SC008 | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Stable cell line expressing lacZ (full length β-Galactosidase), GFP and RFP with Blasticidin resistance |
|||
GFP & RFP HEK293 stable cells |
|||
SC009 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Stable cell line expressing GFP and RFP with Blasticidin resistance |
|||
CHO-GFP stable cells (Blasticidin) |
|||
SC039-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: GFP expression stable cells in CHO cell line with Blasticidin resistance |
|||
A549 / GFP stable cells (Blasticidin) |
|||
SC043-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: GFP expression stable cells in A549 human lung cancer cell line with Blasticidin resistance |
|||
Mouse CT26 / GFP Stable Cells |
|||
SC061-G | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: GFP expression stable cell line in Mouse CT26 cells with Puromycin resistance |
|||
Mouse MB49 / GFP Stable Cells |
|||
SC065-G | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: GFP expression stable cell line in Mouse MB49 cells with Puromycin resistance |
|||
Human ES2 / GFP Stable Cells |
|||
SC066-G | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: GFP expression stable cell line in Human ES2 cells with Puromycin resistance |
|||
Huamn SW403 / GFP Stable Cells |
|||
SC067-G | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: GFP expression stable cell line in Human SW403 cells with Puromycin resistance |
|||
Puromycin,Powder |
|||
CR028-001 | GenDepot | 100mg | 230.4 EUR |
Puromycin,Powder |
|||
CR028-005 | GenDepot | 500mg | 619.2 EUR |
Puromycin,Powder |
|||
CR028-101 | GenDepot | 1g | 1081.2 EUR |
Puromycin HCl |
|||
20-abx076662 | Abbexa |
|
|
Puromycin aminonucleoside |
|||
A3740-250 | ApexBio | 250 mg | 1284 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin aminonucleoside |
|||
A3740-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin aminonucleoside |
|||
A3740-50 | ApexBio | 50 mg | 366 EUR |
Description: IC50: N/APuromycin aminonucleoside, 3'-Amino-3'-deoxy-N6,N6-dimethyladenosine, is the aminonucleoside portion of the antibiotic puromycin. Puromycin aminonucleoside (PAN)-induced nephrosis in rats can provide a model for investigating the pathogenesis of severe proteinuric conditions. |
|||
Puromycin dihydrochloride |
|||
B7587-5.1 | ApexBio | 10 mM (in 1mL H2O) | 142.8 EUR |
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA. |
|||
Puromycin dihydrochloride |
|||
B7587-50 | ApexBio | 50 mg | 157.2 EUR |
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA. |
|||
Puromycin Aminonucleoside |
|||
P041-100MG | TOKU-E | 100 mg | 519.6 EUR |
Puromycin Aminonucleoside |
|||
P041-1G | TOKU-E | 1g | 2793.6 EUR |
Puromycin Aminonucleoside |
|||
P041-500MG | TOKU-E | 500 mg | 1636.8 EUR |
Puromycin Dihydrochloride |
|||
P001-1G | TOKU-E | 1 g | 604.8 EUR |
Puromycin Dihydrochloride |
|||
P001-250MG | TOKU-E | 250 mg | 192 EUR |
Puromycin Dihydrochloride |
|||
P001-500MG | TOKU-E | 500 mg | 342 EUR |
Puromycin dihydrochloride |
|||
GA1940-100MG | Glentham Life Sciences | 100 mg | 294 EUR |
Puromycin dihydrochloride |
|||
GA1940-10MG | Glentham Life Sciences | 10 mg | 84 EUR |
Puromycin dihydrochloride |
|||
GA1940-250MG | Glentham Life Sciences | 250 mg | 562.8 EUR |
Puromycin dihydrochloride |
|||
GA1940-25MG | Glentham Life Sciences | 25 mg | 132 EUR |
Puromycin dihydrochloride |
|||
GA1940-500MG | Glentham Life Sciences | 500 mg | 982.8 EUR |
Puromycin (Dihydrochloride) |
|||
HY-B1743A | MedChemExpress | 50mg | 198 EUR |
Puromycin aminonucleoside |
|||
HY-15695 | MedChemExpress | 10mM/1mL | 135.6 EUR |
Puromycin Dihydrochloride |
|||
1860-100 | Biovision | each | 326.4 EUR |
Puromycin Dihydrochloride |
|||
1860-1000 | Biovision | each | 1554 EUR |
Puromycin Dihydrochloride |
|||
1860-25 | Biovision | each | 151.2 EUR |
Puromycin Dihydrochloride |
|||
1860-250 | Biovision | each | 548.4 EUR |
Puromycin Dihydrochloride |
|||
1860-500 | Biovision | each | 966 EUR |
Inducible RFP Hela stable cell line |
|||
SC037 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Inducible RFP expression stable cell line in Hela with Blasticidin and Puromycin resistance |
|||
Hela / Cas9 (Bad) Stable Cell Line |
|||
SC045-Cas9-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1269.6 EUR |
Description: Cas9 expression stable cell line with Blasticidin resistance in Hela human cervical cancer cells. |
|||
Chang Liver (HeLa) |
|||
C0050007 | Addexbio | One Frozen vial | 651.6 EUR |
HeLa Antigen Concentrate |
|||
F813X | Cygnus Technologies | 1 ml | 632.4 EUR |
Description: HeLa Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
HeLa Cell Extract |
|||
30R-AG012 | Fitzgerald | 100 ug | 418.8 EUR |
Description: Glutathiolated human epithelial carcinoma cell (HeLa) extract |
|||
HeLa Cell Slide |
|||
17-001 | ProSci | 1 pack | 216.6 EUR |
Description: HeLa S3 (cervix; adenocarcinoma) |
|||
Human ; HeLa (#1) |
|||
02-723 | Sceti | 100ng | 481.2 EUR |
Description: The Human ; HeLa (#1) is available in Europe and for worldwide shipping via Gentaur. |
|||
HeLa Membrane Lysate |
|||
XBL-10439 | ProSci | 0.1 mg | 619.8 EUR |
Description: Hela (Human cervix Adenocarcinoma) cell membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The Hela (Human cervix Adenocarcinoma) cell was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Hela (cervix Adenocarcinoma) cell membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Hela (cervix Adenocarcinoma) cell membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Hela Nuclear Extract |
|||
X12001 | EpiGentek | 1000 µg | Ask for price |
HeLa Nuclear Extract |
|||
1641-01 | Biovision | each | 222 EUR |
HeLa Nuclear Extract |
|||
1641-1 | Biovision | each | 405.6 EUR |
HEK293 / uGFP (unstable GFP) Stable Cells |
|||
SC058 | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Unstable GFP expression stable cell line in HEK293 cells with Puromycin resistance |
|||
Human B lymphocyte / GFP Stable Cells |
|||
SC060-G | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: RFP expression stable cell line in Human B lymphocyte cells with Puromycin resistance |
|||
Mouse CT26 (Luciferase & GFP) Stable Cells |
|||
SC061-LG | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Luciferase & GFP expression stable cell line in Mouse CT26 cells with Puromycin resistance |
|||
Mouse MB49 / Luciferase & GFP Stable Cells |
|||
SC065-LG | GenTarget | 2 x 106 cell/ml x 1ml | 3540 EUR |
Description: Luciferase & GFP expression stable cell line in Mouse MB49 cells with Puromycin resistance |
|||
Human ES2 / Luciferase & GFP Stable Cells |
|||
SC066-LG | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Luciferase & GFP expression stable cell line in Human ES2 cells with Puromycin resistance |
|||
A549 / Luciferase (Puromycin) stable cell line |
|||
SC043-Luc | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker. |
|||
Puromycin-5'-Triphosphate |
|||
B7975-.01 | ApexBio | 10 µl (100 mM) | 300 EUR |
Puromycin-5'-Triphosphate |
|||
B7975-.05 | ApexBio | 50 µl (100 mM) | 1206 EUR |
Puromycin-5'-Triphosphate |
|||
B7975-.1 | ApexBio | 100 µl (100 mM) | 2164.8 EUR |
O-Propargyl-Puromycin |
|||
HY-15680 | MedChemExpress | 10mM/1mL | 502.8 EUR |
O-Propargyl-puromycin |
|||
B2590-1000 | Biovision | each | 483.6 EUR |
O-Propargyl-puromycin |
|||
B2590-500 | Biovision | each | 288 EUR |
EZSolution? Puromycin Dihydrochloride |
|||
1861-100 | Biovision | each | 366 EUR |
HeLa/Cas9 Cell Line |
|||
AKR-5111 | Cell Biolabs | 1 vial | 686.4 EUR |
HeLa HCP ELISA Kit |
|||
F810 | Cygnus Technologies | 1 kit (96 wells plate) | 1296 EUR |
Description: HeLa HCP ELISA Kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-HeLa: HRP Conjugate |
|||
F811 | Cygnus Technologies | 12 ml | 678 EUR |
Description: Anti-HeLa: HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
|||
Native Nucleosome (HeLa-derived) |
|||
52039 | BPS Bioscience | 0.6 mg | 695 EUR |
Description: Native nucleosome purified from human HeLa cells. |
|||
Human HeLa cells (Heat shocked) total protein lysate for western control for hsps |
|||
HSP704-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
PiranhaTM HEK293T GFP/Puromycin Stable Cell Line (>1x10^6 cell/vial) |
|||
PTPD600A-1 | SBI | 1 vial | 1358.4 EUR |
luciferase (firefly), HEK293 stable cells (GFP-Blasticidin) |
|||
SC002-GB | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Luciferase (firefry) stable cell line with GFP-Blasticidin dual marker. |
|||
Human B lymphocyte (Luciferase / GFP) Stable Cells |
|||
SC060-LG | GenTarget | 2 x 106 cell/ml x 1ml | 3540 EUR |
Description: Luciferase & GFP expression stable cell line in Human B lymphocyte cells with Puromycin resistance |
|||
LacZ stable cells |
|||
SC003 | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: LacZ (β-Galactosidase) stable cell line in HEK293 cell line with Blasticidin resistance |
|||
TAT stable cells |
|||
SC012 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Stable cell line expressing codon humanized TAT gene and RFP with Blasticidin resistance |
|||
Green Fluorescent Protein (GFP-fusion protein) ELISA Kit, 96 tests, Quantitative |
|||
800-420-GFP | Alpha Diagnostics | 1 kit | 854.4 EUR |
O-propargyl-puromycin (OPP) |
|||
A8778-5 | ApexBio | 5 mg | 12430.8 EUR |
Description: An alkyne derivative of puromycin used to supervise newly protein synthesis, named O-propargyl-puromycin (OPP), is a potent protein synthesis inhibitor that stopping translation through be incorporated into the C-terminus of translating polypeptide chains. |
|||
Puromycin HCl (Translation inhibitor) |
|||
SIH-248-250MG | Stressmarq | 250 mg | 292.8 EUR |
Description: The substance Puromycin HCl is a translation inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white powder which is May be dissolved in DMSO (50 mg/ml); or water (50 mg/ml). |
|||
Puromycin HCl (Translation inhibitor) |
|||
SIH-248-50MG | Stressmarq | 50 mg | 129.6 EUR |
Description: The substance Puromycin HCl is a translation inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white powder which is May be dissolved in DMSO (50 mg/ml); or water (50 mg/ml). |
|||
Cas9 Lentivirus (Puromycin Selection) |
|||
78066 | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene._x000D_ Cas9 Lentivirus can be used to generate Cas9 expressing cells in almost any mammalian cell line. Cells stably expressing Cas9 can then be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines._x000D_ The Cas9 Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a Cas9 gene driven by an EF1a promoter, along with a Puromycin selection marker._x000D_ |
|||
Renilla Luciferase Lentivirus (Puromycin) |
|||
79565-P | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The Renilla Luciferase (Rluc) Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express Renilla luciferase under a CMV promoter. |
|||
Firefly Luciferase Lentivirus Puromycin |
|||
79692-P | BPS Bioscience | 500 µl x 2 | 875 EUR |
Description: The Firefly Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. This virus constitutively express firefly luciferase under a CMV promoter. |
|||
HeLa HCP Std. A-H |
|||
F813 | Cygnus Technologies | 1 ml | 585.6 EUR |
Description: HeLa HCP Std. A-H by Cygnus Technologies is available in Europe via Gentaur. |
|||
HeLa Cell Lysate (Whole Cell) |
|||
LYSATE0001 | Cusabio | 200ug | 180 EUR |
Description: This whole cell lysate is prepared from Hela cells using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
Human Hela Whole Cell Lysate |
|||
LYSATE0023 | BosterBio | 200ug | 180 EUR |
Description: This cell lysate is prepared from human hela using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
Anti-HeLa HCP, Affinity Purified |
|||
HL59/73-AF | Cygnus Technologies | 1 mg | 2295.6 EUR |
Description: Anti-HeLa HCP, Affinity Purified by Cygnus Technologies is available in Europe via Gentaur. |
|||
HeLa Nuclear Extract (DTT-free) |
|||
7947-01 | Biovision | each | 222 EUR |
HeLa Nuclear Extract (DTT-free) |
|||
7947-1 | Biovision | each | 379.2 EUR |
Cas9-Expressing HeLa Cell Pool |
|||
78161 | BPS Bioscience | 2 vials | 795 EUR |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing HeLa cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. |
|||
CRISPRa (SAM) HeLa Cell Line |
|||
78193 | BPS Bioscience | 2 vials | 2500 EUR |
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR associated protein 9), lacking any endonuclease activity, fused to transcriptional activator VP64. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag, which is maintained with Hygromycin resistance. When these cells are transfected with an MS2- tagged sgRNA targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the genomic DNA and begin transcription, inducing expression of the desired gene. |
|||
ACE2 - HeLa Recombinant Cell Line |
|||
79958 | BPS Bioscience | 2 vials | 4950 EUR |
Description: Recombinant clonal stable HeLa cell line constitutively expressing full length human ACE2, Genbank #NM_021804.3). Surface expression of ACE2 was confirmed by flow cytometry. |
|||
Human HeLa cells (normal/non-heat shocked) total protein lysate for western control for hsps |
|||
HSP703-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
HEK293-RFP stable cells |
|||
SC007 | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
Description: Humanized Red fluorescent protein (RFP) stable cell line with Blasticidin resistance |
|||
HEK293-CFP stable cells |
|||
SC010 | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
Description: Stable cell line expressing CFP with Blasticidin resistance |
|||
HEK293-YFP stable cells |
|||
SC011 | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
Description: Stable cell line expressing YFP with Blasticidin resistance |
|||
Glutamine Synthesis stable cells |
|||
SC013 | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Stable cell line expressing Glutamine Synthesis gene and RFP with Blasticidin resistance |
|||
h LIN28 stable cells |
|||
SC016 | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
Description: Stable cell line expressing human Lin28 gene and RFP with Blasticidin resistance |
|||
0.1 G PUROMYCIN DIHYDROCHLORIDE, POWDER |
|||
61-385-RA | CORNING | 0,1 g/pk | 195.6 EUR |
Description: Media Catalog; Cell Culture Reagents |
|||
Puromycin dihydrochloride from Streptomyces alboniger |
|||
abx082477-25mg | Abbexa | 25 mg | 376.8 EUR |
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103502 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103503 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody |
|||
20-abx103504 | Abbexa |
|
|
Active Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-APE206Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
|||
shRNA-H1 (Neg)-(Puromycin) lentivirus |
|||
H1(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
pGL3- U6- sgRNA- PGK- puromycin |
|||
PVT10975 | Lifescience Market | 2 ug | 361.2 EUR |
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
Recombinant Puromycin Sensitive Aminopeptidase (PSA) |
|||
4-RPE206Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Puromycin Sensitive Aminopeptidase expressed in: E.coli |
|||
shRNA-U6 (Neg)-(Puromycin) lentivirus |
|||
U6(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made lentiviral shRNA expression particles under human U6 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
Expression Negative Control Lentivirus (Puromycin) |
|||
79902-P | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_ |
|||
Firefly Luciferase-eGFP Lentivirus (Puromycin) |
|||
79980-P | BPS Bioscience | 500 µl x 2 | 875 EUR |
Description: The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and eGFP cassette (Luc-P2A-eGFP) driven by a CMV promoter. Both the luciferase and eGFP are coexpressed under the CMV promoter in the transduced cells, allowing greater flexibility for detection of transduced cells. |
|||
Purified Exosomes: HeLa Human Cell Line |
|||
EXOP-405A-1 | SBI | 50 µg | 409 EUR |
Inducible h P53 stable cells |
|||
SC014 | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Inducible expression stable cell line for human P53 gene, containing RFP-Blasticidin fusion marker and Puromycin resistance. |
|||
h OCT3/4 stable cells |
|||
SC015 | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
Description: Stable cell line expressing human OCT3/4 gene and RFP with Blasticidin resistance |
|||
A549 / TetR (Puro) stable cells |
|||
SC043-TetR | GenTarget | 2 x 106 cell/ml x 1ml | 1104 EUR |
Description: Tetracycline repressor expression stable cell line with Puromycin marker in A549 human lung cancer cells. |
|||
Mouse CT26 / PDL1 Stable Cells |
|||
SC061-PDL1 | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Huamn PDL-1 expression stable cell line in Mouse CT26 cells with Puromycin resistance |
|||
Mouse CT26 / RFP Stable Cells |
|||
SC061-R | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: RFP expression stable cell line in Mouse CT26 cells with Puromycin resistance |
|||
Mouse MB49 / RFP Stable Cells |
|||
SC065-R | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: RFP expression stable cell line in Mouse MB49 cells with Puromycin resistance |
|||
Human ES2 / RFP Stable Cells |
|||
SC066-R | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: RFP expression stable cell line in Human ES2 cells with Puromycin resistance |
|||
Huamn SW403 / Luciferase Stable Cells |
|||
SC067-Luc | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Firefly luciferase expression stable cell line in human SW403 cells with Puromycin resistance |
|||
Luciferase (firefly) and CRE co-expression stable cell line (puromycin) |
|||
SC021-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with Puromycin marker. |
|||
Streptomyces alboniger Puromycin N-acetyltransferase (pac) |
|||
1-CSB-EP319512SNI | Cusabio |
|
|
Description: Recombinant Streptomyces alboniger Puromycin N-acetyltransferase(pac) expressed in E.coli |
|||
Streptomyces alboniger Puromycin N-acetyltransferase (pac) |
|||
1-CSB-EP319512SNIa0 | Cusabio |
|
|
Description: Recombinant Streptomyces alboniger Puromycin N-acetyltransferase(pac) expressed in E.coli |
|||
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068793 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068794 | Abbexa |
|
|
Mouse Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
20-abx068795 | Abbexa |
|
|
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
abx670073-01mg | Abbexa | 0.1 mg | 594 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) Protein |
|||
abx670074-02mg | Abbexa | 0.2 mg | 678 EUR |
Puromycin Sensitive Aminopeptidase (PSA) Antibody (Biotin) |
|||
20-abx272551 | Abbexa |
|
|
Puromycin Sensitive Aminopeptidase (PSA) Antibody (Biotin) |
|||
20-abx273008 | Abbexa |
|
|
CMV-Luciferase (firefly)-2A-RFP (Puromycin) |
|||
LVP324 | GenTarget | 1x107 IFU/ml x 200ul | 418.8 EUR |
Description: Pre-made lentiviral particles expressing firefly luciferase with RFP and Puromycin dual marker, provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
TCR Activator Lentivirus (CMV Promoter/Puromycin) |
|||
79894-CP | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The TCR Activator Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a gene for a membrane-bound, engineered T cell receptor (TCR) activator driven by a CMV promoter or an EF1a promoter. After transduction, the expression of TCR activator can be monitored in the target cells. |
|||
TCR Activator Lentivirus (EF1a Promoter/Puromycin) |
|||
79894-EP | BPS Bioscience | 500 µl x 2 | 795 EUR |
Description: The TCR Activator Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a gene for a membrane-bound, engineered T cell receptor (TCR) activator driven by a CMV promoter or an EF1a promoter. After transduction, the expression of TCR activator can be monitored in the target cells. |
|||
cDNA from Human Tumor Cell Line: Hela |
|||
C1255811 | Biochain | 40 reactions | 451.2 EUR |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
HeLa Cell Lysate (Human epithelial Cell Line) |
|||
LF-R0001 | Abfrontier | 200 ul | 103.2 EUR |
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate |
|||
Human HeLa-S3 (Cervix Epithelioid Carcinoma) lysate |
|||
HCL-1201 | Alpha Diagnostics | 100ug | 285.6 EUR |
Human HeLa Whole Cell Lysate, TNFa Stimulated |
|||
HCL-2000 | Alpha Diagnostics | 100ug | 255.6 EUR |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract |
|||
HCL-2008 | Alpha Diagnostics | 100ug | 270 EUR |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate |
|||
HCL-2009 | Alpha Diagnostics | 1 mg | 628.8 EUR |
Dendritic Cells/B Cells Antibody |
|||
abx412775-02mg | Abbexa | 0.2 mg | 678 EUR |
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
516-A-01mg | Virogen | 0,1 mg | 321 EUR |
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
516-A-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
Luciferase (firefly) and CRE co-expression stable cell line (RFP-puromycin) |
|||
SC021-RP | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with RFP-Puromycin fusion dual marker. |
|||
luciferase (firefly), HEK293 stable cells (Blasticidin) |
|||
SC002-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
Description: Luciferase (firefry) stable cell line with Blasticidin marker. |
|||
luciferase (firefly), HEK293 stable cells (Neomycin) |
|||
SC002-Neo | GenTarget | 2 x 106 cell/ml x 1ml | 843.6 EUR |
Description: Luciferase (firefry) stable cell line with Neomycin marker. |
|||
CRE stable cells with Blasticidin marker |
|||
SC004-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
Description: CRE recombinase stable cell line with Blasticidin resistance |
|||
CRE stable cells with Neomycin marker |
|||
SC004-Neo | GenTarget | 2 x 106 cell/ml x 1ml | 1365.6 EUR |
Description: CRE recombinase stable cell line with Neomycin resistance |
|||
NCI-H1299 / Luciferase (Puro) Stable Cells |
|||
SC053-L | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Luciferse (firefly) expression stable cell line in NCI-H1299 cells with Puromycin resistance |
|||
CFPAC-1 / Luciferase (Puro) Stable Cells |
|||
SC054-L | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
Description: Luciferse (firefly) expression stable cell line in CFPAC-1 cells with Puromycin resistance |
|||
mouse CT26 / TetR (Bsd) stable cells |
|||
SC056-TetR | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Tetracycline repressor expression stable cell line with Blasticidin marker in mouse CT26 cells. |
|||
Human B lymphocyte / RFP Stable Cells |
|||
SC060-R | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: GFP expression stable cell line in Human B lymphocyte cells with Puromycin resistance |
|||
Mouse CT26 (Luciferase & RFP) Stable Cells |
|||
SC061-LR | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Luciferase & RFP expression stable cell line in Mouse CT26 cells with Puromycin resistance |
|||
Mouse MB49 / Luciferase & RFP Stable Cells |
|||
SC065-LR | GenTarget | 2 x 106 cell/ml x 1ml | 3540 EUR |
Description: Luciferase & RFP expression stable cell line in Mouse MB49 cells with Puromycin resistance |
|||
Human ES2 / Luciferase & RFP Stable Cells |
|||
SC066-LR | GenTarget | 2 x 106 cell/ml x 1ml | 2670 EUR |
Description: Luciferase & RFP expression stable cell line in Human ES2 cells with Puromycin resistance |
|||
Human ES2 / TetR (Puro) Stable Cells |
|||
SC066-TetR | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
Description: Tetracycline repressor expression stable cell line with Puromycin resistance in human ES-2 cells. |
|||
Genomic DNA from Human Tumor Cell Line: Hela |
|||
D1255811 | Biochain | 100 ug | 291.6 EUR |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
Total Protein from Human Tumor Cell Line: Hela |
|||
P1255811 | Biochain | 1 mg | 256.8 EUR |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
p300 protein WB +ve control (HeLa nuclear extract) |
|||
P3001-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
Membrane Protein from Human Tumor Cell Line: Hela |
|||
P3255811 | Biochain | 0.1 mg | 342 EUR |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
Total RNA from Human Tumor Cell Line: Hela |
|||
R1255811-50 | Biochain | 50 ug | 232.8 EUR |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
Recombinant Legionella Pneumophila helA Protein (aa 1-1052) |
|||
VAng-Lsx3644-inquire | Creative Biolabs | inquire | Ask for price |
Description: Legionella Pneumophila Protein HelA, recombinant protein. |
|||
GFP Expressing Human Umbilical Vein Endothelial Cells |
|||
GF01 | Neuromics | 500,000+ Cells frozen | 1248 EUR |
Puromycin Solution, 10mg/ml , Cell Cultere Tested |
|||
CR026-001 | GenDepot | 10ml | 241.2 EUR |
Human NPEPPS/ Puromycin-sensitive aminopeptidase ELISA Kit |
|||
E1772Hu | Sunlong | 1 Kit | 685.2 EUR |
Human Puromycin Sensitive Aminopeptidase (PSA) ELISA Kit |
|||
DLR-PSA-Hu-48T | DL Develop | 48T | 620.4 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Human Puromycin Sensitive Aminopeptidase (PSA) in samples from tissue homogenates, cell lysates or other biological fluids. |